TrivarX Limited (ASX:TRI)

Australia · Delayed Price · Currency is AUD

0.0230

+0.0010 (4.55%)

Jun 16, 2026, 1:58 PM AEST

130.00% (1Y)

Market Cap	26.53M +258.0%
Revenue (ttm)	-95.36K +16.0%
Net Income	-2.11M
EPS	-0.00
Shares Out	1.15B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	515,684
Open	0.0230
Previous Close	0.0220
Day's Range	0.0230 - 0.0230
52-Week Range	0.0070 - 0.0350
Beta	0.86
Analysts	n/a
Price Target	6.00 (+25,986.96%)
Earnings Date	Aug 28, 2026

About TrivarX

TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Hawthorn East, Australia... [Read more]

Industry Health Information Services

Sector Healthcare

Founded 1987

Employees 6

Stock Exchange Australian Securities Exchange

Ticker Symbol TRI

Full Company Profile

Financial Performance

In fiscal year 2025, TrivarX's revenue was 1.03 million, an increase of 16.00% compared to the previous year's 888,829. Losses were -943,231, -34.25% less than in 2024.

Financial Statements